Contrast-Enhanced Mammography: A Newer Option
SaveContrast-enhanced mammography (CEM) is a mammogram that uses injected iodine dye to highlight increased blood flow, which cancers tend to create. It combines a standard mammogram with contrast in one study and is used mainly for dense breasts, problem-solving, or as a faster, more accessible alternative to breast MRI.
Last updated: July 2026
What is contrast-enhanced mammography?
Contrast-enhanced mammography is a standard digital mammogram performed just after an injection of iodine-based contrast. The scanner takes two exposures at different energies and subtracts them, producing one image of normal breast tissue and another that lights up areas of extra blood flow, the pattern that tumors, which build their own blood supply, tend to show. Images are usually captured about 2 to 7 minutes after the contrast is given, and the whole visit runs close to 10 minutes of imaging. Because it adds only contrast and processing to familiar mammography equipment, many centers can offer CEM without the separate scanner a breast MRI requires. The added information helps distinguish suspicious areas from harmless ones.
Who might benefit from CEM?
Dense breast tissue and problem-solving are the two situations where CEM comes up most. According to breast-imaging guidance, dense tissue appears white on a mammogram, the same color as many tumors, which lowers a standard mammogram's sensitivity, a recognized limitation of screening in dense breasts 1Ref 1National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Breast Cancer Screening.Supports that dense breast tissue lowers the sensitivity of standard mammography, a recognized limitation motivating supplemental imaging.. CEM can also help clarify an uncertain mammogram or ultrasound finding, or map the extent of a known cancer before treatment. Breast density tends to be higher before menopause and often decreases across the menopausal transition, which is one reason supplemental imaging is discussed more often for younger women 2Ref 2American College of Obstetricians and Gynecologists (2017).Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women.Supports that breast density is a screening consideration and that supplemental imaging is discussed based on density and risk.. If you have been told you have dense breasts after a routine mammogram, CEM is one of several supplemental options a clinician may raise.
How does CEM compare with breast MRI?
CEM and breast MRI both use contrast to reveal blood flow, and early studies suggest their cancer-detection performance is broadly comparable, though MRI remains the more established test. The practical differences favor access: CEM takes about 10 minutes versus roughly 30 to 45 minutes for MRI, generally costs less, and can run on mammography equipment many centers already own. For people who cannot tolerate an MRI, whether because of claustrophobia, certain implants, or long scan times, CEM offers a shorter alternative. MRI is still the guideline-recommended supplemental screen for women at high lifetime risk, such as those with a BRCA gene change, so the choice depends on why the imaging is being done 3Ref 3National Cancer Institute (2024).BRCA Gene Changes: Cancer Risk and Genetic Testing Fact Sheet.Supports that women at high lifetime risk, such as those with a BRCA gene change, are advised to have breast MRI as supplemental screening..
What happens during and after the scan?
A CEM visit feels much like a regular mammogram with one added step. A technologist places a small intravenous line and injects the iodine contrast, then positions the breast for compression and takes the paired images over about 10 minutes. Most people feel only a brief warm flush from the contrast. Afterward, the dye clears through the kidneys, usually within about 24 hours, and you can return to normal activity. If CEM highlights an area of concern, the next step is typically a targeted ultrasound or a biopsy to sample the tissue, so knowing how a results timeline works helps. An iodine allergy or kidney problems are the main reasons a clinician might choose a different test.
When to ask about contrast-enhanced mammography
Contrast-enhanced mammography is worth raising when a standard mammogram leaves questions unanswered. Reasonable moments include being told you have dense breasts, needing to work up an uncertain finding, or wanting a supplemental test when MRI is not accessible or tolerable. Routine habits still matter most: knowing your own baseline by checking your breasts and flagging a new breast lump early catch far more than any single scan. Availability varies, since not every imaging center offers CEM yet, so asking what your facility provides is a practical starting point. Gale can help you prepare questions about which breast imaging fits your risk.
Common questions
Related
Breast health
Dense Breasts: Do You Need More Than a Mammogram?Breast health
Dense Breasts: Decoding Your Notification LetterBreast health
HRT and Breast Density: What Changes on Imaging
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When breast imaging needs follow-up
- —A new lump, focal pain, nipple discharge, or skin change is a reason to seek clinical evaluation, whichever imaging you have had.
- —An imaging result labeled suspicious or incomplete is a reason to schedule the recommended follow-up promptly.
- —A known iodine contrast allergy or kidney disease is a reason to tell the imaging team before a contrast study is booked.
- —A breast change you can feel that does not show on imaging is still a reason to ask a clinician about further evaluation.
This article is general health education, not medical advice. Which breast imaging test fits your density and risk is decided with a clinician and radiologist based on your history and prior results.
References
- 1.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Breast Cancer Screening. National Cancer Institute (NCI), NIH. link ✓Supports that dense breast tissue lowers the sensitivity of standard mammography, a recognized limitation motivating supplemental imaging.
- 2.American College of Obstetricians and Gynecologists (2017). Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002158 ✓Supports that breast density is a screening consideration and that supplemental imaging is discussed based on density and risk.
- 3.National Cancer Institute (2024). BRCA Gene Changes: Cancer Risk and Genetic Testing Fact Sheet. National Cancer Institute (NCI), NIH. link ✓Supports that women at high lifetime risk, such as those with a BRCA gene change, are advised to have breast MRI as supplemental screening.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy